How to Help Your Patients Find Edluar in Stock: A Provider's Guide

Edluar (zolpidem tartrate sublingual, 5 mg and 10 mg) is one of those medications that patients increasingly show up asking about — frustrated, medication in hand, unable to fill it. Unlike the broad zolpidem market where generics are plentiful and cheap, Edluar's sublingual formulation occupies a specialty niche that most pharmacies don't stock routinely.

This guide gives you practical steps to help your patients navigate Edluar access — from pharmacy strategies to prior authorization tips and clinical decision-making about when it's worth the effort versus when switching is more pragmatic.

Why Patients Struggle to Fill Edluar Prescriptions

Edluar is a brand-name-only sublingual zolpidem product manufactured by Viatris. It's FDA-approved for sleep-onset insomnia and requires no prior authorization to prescribe — but getting it dispensed is another matter. The access barriers are structural:

• Most chain pharmacies don't stock it. Automated pharmacy ordering systems stock based on prescription volume. Edluar's narrow market means it's rarely auto-ordered.
• No widely available generic sublingual. The FDA approved a generic, but it's not commercially widely distributed. So patients are stuck with the brand price unless insurance covers it.
• Insurance often requires prior authorization. Most plans classify Edluar as non-preferred brand with PA or step therapy requirements.

Strategy 1: Direct Patients to medfinder

The fastest way to help a patient locate Edluar is to send them to medfinder for Providers. medfinder contacts pharmacies near the patient's location to check who has Edluar in stock and can fill their prescription, then texts the results directly to the patient.

This saves hours of patient phone calls and pharmacy run-arounds — and reduces the likelihood of medication abandonment or non-adherence due to access frustration. Consider adding a note in your discharge summary or after-visit summary directing patients to this resource when you prescribe Edluar.

Strategy 2: Recommend Independent Pharmacies Over Chains

Independent pharmacies are significantly more likely than chain pharmacies to stock or be able to order specialty medications like Edluar. They typically:

• Have access to different wholesalers with broader specialty medication inventories
• Can place special orders for non-stocked medications within 24-48 hours
• Have more flexibility in their controlled substance ordering allocations
• Build individual patient dispensing relationships — and may stock Edluar ongoing once a patient establishes there

Advise patients to ask: "Do you carry Edluar (zolpidem tartrate sublingual 5 mg or 10 mg)? If not, can you special-order it?"

Strategy 3: Proactive Prior Authorization

If a patient's insurance requires prior authorization for Edluar, initiating PA before the patient goes to the pharmacy prevents the fill from being rejected and eliminates a frustrating wait. When completing PA:

• Document the clinical rationale for sublingual versus oral formulation (e.g., dysphagia, faster-onset requirement, or oral formulation intolerance)
• If step therapy is required, document prior trial with generic zolpidem IR, including duration, effectiveness, and reasons it was inadequate
• Note the FDA gender-differentiated dosing and document that the appropriate dose has been prescribed for the patient's sex and age

Strategy 4: Discuss Cost Early in the Visit

Brand Edluar can cost $200-$400+ for 30 tablets without insurance. For uninsured or underinsured patients, this is often prohibitive. Having this conversation proactively:

• Ask whether the patient has prescription drug coverage and whether Edluar is on their formulary
• Mention that Viatris (the manufacturer) has a patient assistance program for qualifying uninsured patients
• Note that generic zolpidem IR is the equivalent active ingredient at a fraction of the cost — if the sublingual route isn't medically essential, this may be sufficient

Strategy 5: Know When to Switch

Sometimes the most pragmatic clinical decision is a therapeutic switch. Consider switching to generic zolpidem IR, eszopiclone, or trazodone when:

• The patient doesn't specifically require sublingual delivery
• Cost is prohibitive and PA has been denied
• Repeated pharmacy access failures are causing non-adherence or sleep deprivation
• The patient has risk factors that make a controlled substance alternative preferable (e.g., history of substance use disorder)

See our full clinical alternatives guide: Alternatives to Edluar If You Can't Fill Your Prescription.

Quick Provider Workflow: Edluar Access Checklist

• At prescribing: ask about insurance coverage and cost concerns upfront
• In after-visit summary: include a note directing patient to medfinder.com or an independent pharmacy
• If PA required: submit proactively with documented clinical rationale for sublingual route
• At follow-up: ask if the patient was able to fill the prescription — non-adherence due to access is common and rarely volunteered
• If still unable to fill: switch to generic zolpidem IR, eszopiclone, or trazodone based on patient profile